GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A <i>Streptococcus</i>
Group A <i>Streptococcus</i> (GAS) causes about 500,000 annual deaths globally, and no vaccines are currently available. The Group A Carbohydrate (GAC), conserved across all GAS serotypes, conjugated to an appropriate carrier protein, represents a promising vaccine candidate. Here, we explored the p...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2022-06-01
|
| סדרה: | Vaccines |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2076-393X/10/7/1034 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
